Share

Winsan (Chengdu) Medical Science and Technology Co., Ltd. Stocks

CN¥ 0Last Updated 23.03.2026

Issuer Rating

1/7
Performance

Poor

Risk

High

Recommendation

Sell

Market Cap

CN¥ 20.80M

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
CN¥ 0
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly overvalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Winsan (Chengdu) Medical Science and Technology Co., Ltd. engages in the medical informatization, telemedicine, Internet health management, medical equipment, and medical services in China. It offers health information system that provides regional population health, Chinese medicine, and hospital performance management informationization, as well as home pension, chronic disease management, remote diagnosis and treatment, medical insurance, and pharmacy services. The company also operates Jingde County Chinese Medicine Hospital, a non-profit second-class Chinese medicine hospital. It provides medical testing reagents, instruments, consumables, and other products to medical institutions and clinical medical examination services. The company was formerly known as Winsan (Shanghai) Medical Science and Technology Co., Ltd. and changed its name to Winsan (Chengdu) Medical Science and Technology Co., Ltd. in April 2020. The company was founded in 1993 and is headquartered in Shanghai, China.

Company Valuation

Greatly overvalued
1/7

Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks